Xue Yang

The University of Texas MD Anderson Cancer Center

Also affiliated with The University of Texas at San Antonio Health Science Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research, The University of Texas Health Science Center at Houston

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma”.

Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0031

N/A

0.388DataRank · unranked

6 citations

Michael Tidwell, Henriette U. Balinda, Nicholas A. Clanton, Xue Yang, Suryavathi Viswanadhapalli +10 more

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling

International Journal of Molecular Sciences(2023)10.3390/ijms242417426

N/A

0DataRank · unranked

13 citations

Alondra L. Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy Medina, Xue Yang +11 more

Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis

npj Precision Oncology(2024)10.1038/s41698-024-00612-y

N/A

0DataRank · unranked

20 citations

Suryavathi Viswanadhapalli, Uday P. Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata +19 more

PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0173

N/A

0DataRank · unranked

3 citations

Xue Yang, Adriana Baker, Rahul Gopalam, William C. Arnold, Timilehin T. Adeniran +10 more